Chromium complex with insulin-like activity

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S043000, C514S045000, C514S046000

Reexamination Certificate

active

11022205

ABSTRACT:
A chromium complex for use in treating metabolic disorders, particularly Type 1 and Type 2 diabetes.

REFERENCES:
patent: 3925433 (1975-12-01), Abdel-Monem et al.
patent: 4242257 (1980-12-01), Silio
patent: 4923855 (1990-05-01), Jensen
patent: 5872102 (1999-02-01), Vincent et al.
patent: 5969116 (1999-10-01), Martin
patent: 6258848 (2001-07-01), Fantus
patent: 6365176 (2002-04-01), Bell et al.
patent: 6444231 (2002-09-01), Vincent et al.
patent: 6689383 (2004-02-01), Anderson et al.
patent: 6689385 (2004-02-01), Richardson et al.
patent: 6713469 (2004-03-01), de la Harpe et al.
patent: 6809115 (2004-10-01), Katz et al.
Bossard et al. Journal of Biological Chemistry (1981), vol. 256, pp. 6617-6622.
A Glucose Tolerance Factor and its Differentiation from Factor 3, K. Schwarz; W. Mertz, Arch. Biochem. Biophys. 72:515-518, 1957.
Chromium(III)and the Glucose Tolerance Factor, K. Schwarz; W. Mertz, Arch. Biochem. Biophys. 85:292-295, 1959.
The bioinorganic chemistry of chromium(III), J.B. Vincent, Polyhedron, 20:1-26, 2001.
Recent advances in the nutritional biochemistry of trivalent chromium, J.B. Vincent, Proceedings of the Nutrition Society, 63:41-47, 2004.
Present knowledge of the role of chromium, W. Mertz; E.W. Toepfer; E.E. Roginski; M.M. Polansky; Fed. Proc. 33:2275-2280, 1974.
On the nature of the glucose tolerance factor from yeast, T. Urcemow; O.H. Wieland, Horm. Metab. Res. Suppl. 16:51-54, 1984.
Extracts of brewer's yeast contain gaba which enhances activation fo glycogen synthetase by insulin in isolated rat hepatocytes, E.S. Holdsworth; E. Neville, Biochem. Int. 17:1107-1116, 1988.
Effects of extracts of high-and low-chromium brewer's yeast on metabolism of glucose by hepatocytes from rats fed on high-or low-Cr diets, E.S. Holdsworth; E. Neville, British Journal of Nutrition, 63: 623-630, 1990.
A fraction derived from brewer's yeast inhibits cholesterol synthesis by rat liver preparationsin vitro, E.S. Holdsworth; D.V. Kaufman; E. Neville, British Journal of Nutrition, 65:285-299, 1991.
Isolation of a biologically active low-molecular-mass chromium compound from rabbit liver, A. Yamamoto; O. Wada; T. Ono, Eur. J. Biochem, 165:627-631, 1987.
Evidence that chromium is an essential factor for biological activity of low-molecular-weight, chromium-binding substance, A. Yamamoto; O. Wada; S. Wanabe, Biochem. Biophys. Res. Comm. 163:189-193, 1989.
Is glucose tolerance factor an artifact produced by acid hydrolysis of low-molecular-weight chromium-binding substance?, K.H. Sumrall; J.B. Vincet, Polyhedron 16:4171-4177, 1997.
A biologically active form of chromium may activate a membrane phosphotyrosine Phosphatase(PTP), C.M. Davis; K.H. Sumrall; J.B. Vincent, Biochemistry 35:12963-12969, 1996.
Chromium Oligopeptide Activates Insulin Receptor Tyrosine Kinase Activity, C.M. Davis; J.B. Vincent, Biochemistry 36:4382-4385, 1997.
Isolation and chracterization of a biologically active chromium oligopeptide from bovine liver, C.M. Davis; J.B. Vincent, Arch. Biochem. Biophys. 339:335-343, 1997.
Composition and biological activity of chromium-pyridine carboxylate complexes, G.W. Evans, Int. J. Biosocial Med. And Res. 11:163-180, 1989.
The biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ decreases plasma cholesterol and triglycerides in rates: towards chromium-continaing therapeutics, Y. Sun; K. Mallya; J. Ramirez; J.B. Vincent, J. Biol. Inorg. Chem. 4:838-845, 1999.
The biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic rats, Y. Sun; B.J. Clodfelder, A.A. Shute, T. Irvin; J.B. Vincent, J. Biol. Inorg. Chem. 7:852-862, 2002.
Insulin-like activity of chromium-binding fractions from brewer's yeast, D.L. Hwang; Y-C Tay; A. Lev-Ran, Biochimica et Biophysica Acta. 882:331-336, 1986.
Chromium-associate 32 P-labeling of proteins, D.L. Hwang; A. Lev-Ran; T. Papoian; W.K. Beech, J. Inorg. Biochem. 30:219-225, 1987.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Chromium complex with insulin-like activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chromium complex with insulin-like activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chromium complex with insulin-like activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3829459

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.